Bexsero Dose Reminder

Thank you for signing up to receive a reminder for when you are due to receive your next BEXSERO dose! You will receive an email shortly confirming your registration.

Thank you for signing up to receive a reminder for when you are due to receive their next BEXSERO dose! You will be sent a confirmation text message. You must reply with YES to the text to confirm your enrolment.

Thank you for signing up to receive a reminder for when you are due to receive their next BEXSERO dose! You will receive an email shortly confirming your registration and you will also be sent a confirmation text message. You must reply with YES to the text to confirm your enrolment.

Children, adolescents, or adults, 2 through 25 years of age

Individuals should receive 2 doses, given at least 1 month apart. An additional booster injection may be considered in individuals at continuous risk of exposure to meningococcal disease.

Would you also like to add a reminder to your calendar?

Add to Calendar 10/01/199510/01/1996Talk to my healthcare provider about BexseroTalk to my healthcare provider about Bexsero.15aqDgWGntMzrikvufamhW32681

BEXSERO multicomponent meningococcal B vaccine (recombinant, adsorbed) is a vaccine for the prevention of meningococcal disease caused by Neisseria meningitidis group B bacteria in individuals from 2 months through 25 years of age. BEXSERO is not expected to protect against all circulating meningococcal serogroup B strains and does not offer protection against strains A, C, Y, and W-135. As with any vaccine, BEXSERO may not fully protect all of those who are vaccinated. BEXSERO does not treat or reduce the consequences of meningococcal disease, including meningitis, sepsis, and death. The very common side effects (may affect more than 1 in 10 people) after vaccination with BEXSERO (reported in all age groups) were pain/tenderness at the injection site, redness at the injection site, swelling of the skin at the injection site, and hardness of the skin at the injection site. In infants and children (up to 10 years of age), fever can occur more frequently when BEXSERO is given at the same time as routine infant vaccines. Allergic reactions may also occur. Ask your healthcare professional if BEXSERO is right for you. Full product information can be found at http://gsk.ca/bexsero/en. To report an adverse event, please call 1-800-387-7374.

For information about how GSK uses, shares, and protects personal information, including information collected online, please read GSK's Privacy Statement.

Please note: This site does not provide medical advice. The contents of this site are for information purposes only and are not in any way intended to replace or substitute the advice of your healthcare professional. Your healthcare professional is the best source of information regarding your health. This digital channel is not intended as a means for reporting an adverse event (side effect) or complaint for any GlaxoSmithKline product. To report an adverse event or product complaint, please call 1-800-387-7374. This site is intended for use by Canadian residents only.

10287
07/23

How are you tracking your family’s vaccination records? Download a digital tool here